iShares Biotechnology ETF (IBB)
ETF analysis · NASDAQ · Financial Services · Asset Management
$212.20
Market Cap
$10.93B
PE (TTM)
N/A
EPS (TTM)
N/A
Dividend Yield
N/A
Beta
0.70
Day Range
$206.02 – $212.20
52-wk Range
$154.62 – $217.12
Avg Volume
N/A
Volume
1.63M
iShares Biotechnology ETF (IBB) is an exchange-traded fund in the Financial Services sector. Latest price: $212.20. Market cap $10.93B. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →1-Year Price
Proprietary Signals
About iShares Biotechnology ETF
The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U.S. biotechnology sector.
Peers
Recent News
- Invesco's RSPH or iShares' IBB: Which Healthcare ETF Is the Better Long-Term Buy?
- Biotech stocks are surging. How investors can play the new drug innovation boom
- Invesco Pharmaceuticals ETF vs. iShares Biotechnology ETF: Which Is the Better Buy?
- iShares Biotechnology ETF $IBB Shares Sold by Fairvoy Private Wealth LLC
- Moderna Rallies 6% as Money Rotates Into Healthcare; BioNTech and Pfizer Edge Higher
Related
Browse more tickers: sitemap